The new device generation in extracorporeal shockwave lithotripsy for a gentle stone therapy

With the lithogold380 MTS presents a new generation of devices for tissue-friendly and efficient treatment of renal stones and other urological indications. The lithotripter is most notably characterised by its large focus (20 x 101 mm) and low energy peaks (max. 36.9 MPa) which guarantees an effective and kidney-conserving therapy.

The large system focus leads to the destruction of the stone with only one treatment in > 95% of all patients and drastically reduces the follow-up treatment rate.

lithogold380 is particularly suitable for the stone treatment in obese patients. Above all, the limited maximum pressure of the system guarantees a tissue-conserving therapy reducing the requirement for anaesthesia to a minimum.

At a glance:

• High treatment success rate > 95 % with a single treatment
• Reduced requirement for anaesthesia
• Dual imaging with X-ray and ultrasound
• Especially suitable for stone therapy in obese patients
• Deep penetration depth (165 mm) reduces the incidence of treating
  patients in the prone position
• Large focus zone (20 x 101 mm) & peak pressure of 36.9 MPa max. = kidney-conserving lithotripsy
• Minmal side effects
• Latest generation electrohydraulic spark gap lithotripter

Indications in urology:

• Renal Calculi
• Ureteral Calculi

This device is cleared by USA FDA and is not commercially available in the EU.